Predictors of Responsiveness to GLP-1 Receptor Agonists in Insulin-Treated Patients with Type 2 Diabetes

BACKGROUND: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are potent antihyperglycemic agents with beneficial effects on weight, cardiovascular, and renal outcomes. Physicians lack guidance as to which patients with insulin-requiring type 2 diabetes will respond best to GLP-1 RAs with respec...

Descripción completa

Detalles Bibliográficos
Autores principales: Gavigan, Colleen, Donner, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427225/
https://www.ncbi.nlm.nih.gov/pubmed/37589043
http://dx.doi.org/10.1155/2023/9972132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427225/
https://www.ncbi.nlm.nih.gov/pubmed/37589043
http://dx.doi.org/10.1155/2023/9972132

Ejemplares similares